Open Orphan Plc
ORPH.LN
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses; hVIVO and Venn Life Sciences and has offices in London, Dublin, Paris, and the Netherlands. Open Orphan is led by a management team with deep industry and financial experience.
Related content
Investing Ideas
|
Open Orphan kickstarts Covid-19 test (ORPH)
Investing Ideas
|
VIDEO: Open Orphan’s Cathal Friel on pharma services firm’s plans and COVID-19 work (piworld) (ORPH)
News
|
Open Orphan one step closer to breakthrough universal flu vaccine as Phase 3 trials proceed (ORPH)
News
|
Open Orphan’s Cathal Friel on firm’s “milestone” human coronavirus challenge study (ORPH)
News
|
Open Orphan signs £3.2m challenge study deal with upside potential (ORPH)
News
|
Open Orphan primed to support coronavirus vaccine work after bringing in world-leading experts (ORPH)
News
|
Open Orphan brings in hVIVO founder Prof. John Oxford to head up coronavirus committee (ORPH)
Latest Analysis
|
The Shifting Shares review of this year’s Growth and Innovation Forum (Part 2/2)
Investing Ideas
|
VIDEO: Open Orphan’s Cathal Friel details ambitious 2020 plans following £5.3m raise in exclusive presentation (ORPH)
Investing Ideas
|
Open Orphan expects profits within months as it plans role in coronavirus treatment (ORPH)
Open Orphan’s (LSE:ORPH) exec chair has said he “could not have been happier” with the pharma firm’s recent £5.3 million placing, claiming the...
Investing Ideas
|
Open Orphan reveals placing progress following hVIVO merger (ORPH)
Investing Ideas
|
Cathal Friel hails “once in a lifetime” opportunity as Open Orphan/hVIVO merger passes (ORPH)
Investing Ideas
|
Cathal Friel reiterates his full-time executive commitment to Open Orphan as hVIVO merger advances (ORPH)
News
|
Open Orphan signs key contract with Pennsylvania’s SFA Therapeutics (ORPH)
News
|
Open Orphan signs five clients to Genomic Health Data platform ahead of launch (ORPH)
Investing Ideas
|
ValueTheMarkets Podcast 032 - with Maurice Treacy, Chief Commercial Officer of Open Orphan (ORPH)
Sign up for VTM Updates
Top Picks for Q2 2022
View MoreCrypto Corner
Learn your NFTs from your BTCs